Study finds drug that can kill 'Covid-19 virus' in 2 days

Grant Boone
April 6, 2020

In a study published Friday, researchers at Monash University in Melbourne said the anti-parasitic drug Ivermectin was found to halt the SARS-CoV-2 virus from growing in cell culture within 48 hours.

A recent collaborative study conducted by a team from Monash University and the Doherty Institute in Australia has found that a commonly used antiparasitic drug could halt the incubation process of the novel coronavirus and potentially cure COVID-19 positive patients of any ailments caused by the virus.

"We discovered that even a single dose could essentially eliminate all viral RNA by 48 hours which even at 24 hr there was a really significant decrease in it", said research study lead writer Dr Kylie Wagstaff. It must be noted, however, that the study was conducted in vitro - in a controlled environment outside a living organism - and that more credible data would be obtained pending clinical trials on human subjects. "We need to figure out now whether the dosage you can use it at in humans will be effective-that's the next step", Dr. Wagstaff said. The Food and Drug Agency approves the drug as an anti-parasitic drug that is effective in fighting viruses such as HIV, influenza, and Zika. Scientists also did not identify any toxicity of the drug at the time points tested in their samples as well as in drug alone samples they parallelly tested.

While Ivermectin is known to work on the virus, the drug, however, reduces the host cells' ability to clear the infection. Caly is the study's author and senior virus identification specialist from the Victorian Infectious Diseases Reference Laboratory.

"Realistically, it's going to be a while before a vaccine is broadly available".

Covid-19 cases rise by 43, more deaths reported
During the briefing, Mkhize confirmed that there are 1 505 cases of coronavirus, an increase of 43 cases from the previous day. Minister of Health Zweli Mkhize has announced there are 1,505 confirmed cases of the COVID-19 coronavirus in South Africa .

Dr Wagstaff and Professor David Jans of the Monash Biomedicine Discovery Institute started working on the effect of Ivermectin on the virus since the start of the pandemic.

It is to be find out that how effective is this drug in the human beings. The researchers' report is available as a pre-proof paper in Antiviral Research, titled, "The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro".

Dr Wagstaff and also Teacher Jans began exploring whether it serviced the SARS-CoV-2 infection as soon as the pandemic was recognized to have actually begun. The potential use of Ivermectin to combat COVID-19 remains unproven, and depends on funding to progress the work into the next stages.

This article has been republished from the following materials.

Other reports by

Discuss This Article

FOLLOW OUR NEWSPAPER